CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 875 shares at $20.00 ($17,500)
- 8-K Event Regulation FD disclosure
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 3,529 shares at $20.50 ($72,345)
- 4 Open-market sale President and CEO sold 8,210 shares at $19.56 ($160,570)
- 4 Open-market sale President and CEO sold 1,790 shares at $19.55 ($34,987)
- 4 Open-market sale Chief Scientific Officer sold 875 shares at $20.00 ($17,500)
- 4 Open-market sale Chief Financial Officer sold 8,000 shares at $20.00 ($160,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Chief Scientific Officer sold 875 shares at $20.00 ($17,500)
- 4 Open-market sale Chief Scientific Officer sold 7,000 shares at $16.97 ($118,761)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
Page 30 of 36 · 707 filings